SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Plain " 3,232 found 🔀 AI-powered Shuffle
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Why Texas Republican donors give — and why the state matters to GOP fundraising
As the Republican National Committee gathers in Dallas, Republican donors and political experts explain why Texas raises so much money.
Don’t Promote Them. Talk to Them.
Pay matters, but conversations keep people. Brian Walch explains how to build a "Career Compass" to retain your team.
Luma locks down 15-year, $410M fund for life science investments
Luma Group today announced the final close of its inaugural life sciences venture capital fund, totaling $410 million. The New York-based investment firm has had a grip on life sciences since its founding in 2023. The funds unveiled today, dubbed LumaBio Fund I, include investments that have already been made into more than 10 biotechs. They include the likes of eye disease-focused Character Biosciences, rebranded Belgian biotech Coultreon Biopharma and cellular rejuvenation company Altos Labs. The fund saw early success when one of the companies it co-founded, called Vaccine Company, was picked up by Eli Lilly earlier this year for up to $1.55 billion. The acquisition of the in vivo nanoparticle technology-focused biotech formed part of a trio of vaccine buys for the Big Pharma, which has itself been on a prolonged spending spree in 2026. Luma's fund is structured as a 15-year investment with plans to support groundbreaking science and support companies through key milestones from discovery to commercialization, Luma explained in the release. "We founded Luma Group on the belief that extraordinary science, supported by patient, long-term capital, has the power to improve millions of lives," Joshua Fink, founder and managing member of Luma Group, said in the release. "This fund represents more than capital—it is a commitment to partnering with extraordinary innovators as they translate visionary science into life-changing medicines."
Science says we're not special. But here's why that could be wrong – and why we should be thankful we've not been swallowed by the Sun | BBC Sky at Night Magazine
Time and place explain the Sun’s odd chemistry. Analysis of 79 ‘solar twins’ suggests we’re different – but not special.
Marc Overmars steps down as Royal Antwerp sports director due to health issues
Soccer great Marc Overmars is stepping down as Royal Antwerp's sports director due to health issues. Overmars has explained his decision in a letter to supporters.
Overmars resigns as Royal Antwerp sports director due to health issues
Soccer great Marc Overmars is stepping down as Royal Antwerp's sports director due to health issues. Overmars has explained his decision in a letter to supporters. He mentioned fatigue and
Overmars resigns as Royal Antwerp sports director due to health issues
Soccer great Marc Overmars is stepping down as Royal Antwerp's sports director due to health issues. Overmars, who joined the Belgian club in 2022, explained his decision in a letter to supporters published on Wednesday as he mentioned “all the fatigue that has built up over the years and the enormous amount of stress.” “You all know that my health has not been optimal,” he wrote.
Overmars resigns as Royal Antwerp sports director due to health issues
Soccer great Marc Overmars is stepping down as Royal Antwerp's sports director due to health issues. Overmars, who joined the Belgian club in 2022, explained his decision in a letter to supporters published on Wednesday as he mentioned “all the fatigue that has built up over the years and the enormous amount of stress.” “You all know that my health has not been optimal,” he wrote.
OMMA director pushes back on marijuana business complaints
Oklahoma's OMMA is pushing back on claims of slow licensing approvals and strict enforcement in the state's medical marijuana industry.
Review | Cavalluna’s Hong Kong debut was a magical, if cliché, equine spectacle
Cavalluna’s Asian debut stunned the city with its spectacular horsemanship, but plain and flawed storytelling was a fly in the ointment.
World premiere: Shakespeare’s comeback story debuts in I.C.
Scott Carter's new play 'I, Will' imagines Shakespeare's comeback at age 44. Why is the Emmy-winning HBO producer's world premiere launching at Riverside Theatre? He explains it in a Q&A with The Gazette.
Epic v. Health Gorilla: “Working as Designed”
We’ve been on a bit of a legal bender since just before Labor Day, so let’s keep a good thing going! As predicted, Epic does not want its case against Health Gorilla consolidated with the data breach cases, so it filed a motion to vacate the conditional transfer. And because they had to explain to the Panel why this case is different, they put a good chunk of previously unseen Epic v. Health Gorilla discovery record on the public docket! Roll the tape! The Case Against Consolidation Before we get to the fun stuff, let’s do the housekeeping. Epic's motion boils down to three arguments (sorted in ascending order of how well they land): A judge has already decided this. Judge Olguin declined to relate the fraud action to another ELU case (Patterson v. UVA Health), holding that the two do not call for determination of substantially similar questions of law or fact. Epic asks the Panel to treat that (a Rule 42 ruling) as law of the case. The overlap is thin. The three common questions Health Gorilla and the Panel identified are neither numerous nor complex (the qualities the Panel looks for before centralizing). Moreover, they are outnumbered by the questions unique to each side: The breach cases turn on security architecture, notification timing, and patient-level access. The fraud action turns on false treatment attestations and breaches of the framework agreements. Consolidation costs more than it saves. 17 of 21 parties in the fraud action do not appear in a breach case. The cases are also at very different stages: Olguin has a scheduling order running through a January 2028 trial while the breach actions are much more nascent. I like the last two more than the first because they attack the basic economics of an MDL: there just may not be enough shared discovery here to justify dragging all the defendants and a relatively mature fraud case all the way to Florida. On the other hand (while I know exceedingly little about MDL and Rule 42), I have a hard time seeing why a district judge's decision about his own docket would control what the Panel does with the separate § 1407 question. I might be reading between the lines too much, but I sorta think Epic's own brief half-concedes this, framing the two provisions as "two sides of the same coin" but then adding "respectfully submit" (which is often lawyer speak for “we know this is a reach”). The Ladder Gets More Rungs Anyway, the arguments are not why you're here (aside from the lawyers, maybe). Back in June, we discussed how Epic was using the smaller defendants to build an evidentiary ladder toward Health Gorilla and Unit 387. Turns out discovery has been adding a few rungs of its own.
Here is what to do if healthcare costs are eating into your raises
An insurance executive explains how soaring healthcare costs eat into raises, and how workers should discuss alternative options with their company.
Astrocyte changes may explain how stress affects mental health
A new study led by UCLA Health researchers has identified a specific type of brain cell and a tiny structure on its surface that changes when the body is under stress, which may help explain why stress can lead to anxiety and depression.
NASA X-59 explainer: Science of sonic booms
The most common misconception about sonic booms is that they’re just the sound created at the moment when an aircraft “breaks the sound barrier.”
A beginner’s guide to open science
Open science may seem impenetrable for early career researchers. Sarahanne Field explains what it is and how to get started
What Will Life Science Orgs Do When The AI Bill Comes Through?
AI is transforming clinical development, but what happens when usage costs spike? Jon Newton explains how to govern it before the bill lands.
Council backs L.A. fast-food worker scheduling protections as businesses complain of tight margins
The Los Angeles City Council on Tuesday approved an ordinance to extend Fair Work Week scheduling rules to fast-food workers, adding predictable shifts and paid labor-rights training for tens of thous...
Should Kids Have Mental Health Days?
With the school in session, some kids will eventually need to take a sick day. But what about a mental health day? A psychologist explains why those are important too.
Moment of Science: Abundant oxygen not enough to explain massive ancient insects, new study suggests
Unlocking answers about giant ancient insects! Here's why an abundance of oxygen 300 million years ago may not explain why some animals got so gigantic after all.
Sports law professor explains the Clippers and Kawhi Leonard’s NBA punishments
Ken Jacobsen, director of Temple Law’s sports law program, discusses the recent Kawhi Leonard scandal and the heavy punishments being administered by the NBA.
Sports law professor explains the Clippers and Kawhi Leonard’s NBA punishments
Ken Jacobsen, director of Temple Law’s sports law program, discusses the recent Kawhi Leonard scandal and the heavy punishments being administered by the NBA.
The Galaxy Z Fold 8 is outselling Samsung's record-breaking Fold 7 by a wide margin
Samsung finally explained the engineering behind the gap.
New Mexico tribe and pueblos wrap up case that Kalshi sports betting hurts their sovereignty
The New Mexico plaintiffs' filing cites a new appeals court ruling restoring state regulators' oversight of the prediction market.
Scientists Are Still Trying To Understand How the Moon Formed
The Earth and the Moon have nearly identical isotopic compositions, and the Giant Impact Hypothesis strives to explain this. New research into the ancient impact shows how the temperature of both worlds, and how it affects the strength of the materials involved in the collision, shaped the outcome, including the isotopic compositions.
A Chapman Alumnus on How the Executive MBA Program Grew His Business
A Chapman Executive MBA alumnus explains how the program changed his approach to risk and helped grow his business's revenue streams.
‘Antiques Roadshow’ appraisers coming to Fort Plain Museum
Leigh Keno and Joel Bohy of PBS’ “Antiques Roadshow” will offer appraisals during an Oct. 10 antiques show at the Fort Plain Museum.
New-to-science Amazon frog stands out for its slow ‘lazy’ song
Scientists recently described a new species of a tiny brown frog found in the Amazonian floodplain forests of Ecuador and northwestern Brazil. It looks nearly identical to related species but its slow, widely spaced out call sets it apart, researchers note in a study. “I’ve had to get into arguments because people said the frog […]
Years of Dismissed Pain, One Life-Changing Diagnosis
Bronx, NY – For 15 years, Jennifer Grant endured pelvic pain, severe nausea, and fainting episodes that no doctor could fully explain or treat. Dismissed
Moment of Science: Abundant oxygen not enough to explain massive ancient insects, new study suggests
Unlocking answers about giant ancient insects! Here's why an abundance of oxygen 300 million years ago may not explain why some animals got so gigantic after all.
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a flagship biologic in chronic obstructive pulmonary disease (COPD). In detailed results from the late-stage Oberon and Titania trials—first teased in March and detailed in full at the European Respiratory Society Congress in Barcelona this week—the drugmaker laid out the extent of its IL-33 inhibitor’s potential to reduce moderate and severe exacerbations in a wide range of COPD patients still struggling with those “lung attacks,” as AstraZeneca’s Sharon Barr, Ph.D., called them, despite using standard-care inhaled therapy. In the headline results, a 300 mg dose of tozorakimab given once every four weeks curbed those moderate and severe exacerbations in the studies’ primary population of former smokers by 29% in the Oberon study and 34% in Titania. In the overall population of both current and former smokers, these reductions were 30% and 29%, respectively, versus placebo and inhaled standard of care. The benefits also extended to clinically meaningful exacerbation reductions in all prespecified patient subgroups and specifically turned up promising signals in patients across a range of blood eosinophil counts, with Barr telling Fierce that “it’s the details that make this even more exciting than the high-level results that we’ve already shared.” In fact, during AZ’s tozorakimab poster presentation at the ERS 2026 Congress this past weekend, attendees were so enamored by the data that event organizers had to encourage people to clear the room and look at the other presentations on offer, Barr said in an interview. “I think it really speaks to the fact that there is a lot of buzz around these data because the entire respiratory community has been so desperate for new therapies for these patients,” she explained. The respiratory disease continues to represent a “staggering unmet medical need,” Barr said, highlighting the COPD exacerbations that the Oberon and Titania studies homed in on, which she added carry a greater mortality risk than a heart attack. “When a patient has a severe exacerbation, only about half of them are still alive within three and a half years,” she pointed out. As for tozorakimab specifically, Barr christened the molecule “an AstraZeneca science success story,” harkening several years back to the point at which researchers began to explore IL-33 as a driver of respiratory disease, and COPD in particular. At the same time, “there was still so much that wasn’t understood,” she admitted, highlighting the insight that IL-33 signals through both ST2 and EGFR through the RAGE pathway, a discovery Barr attributed to AstraZeneca's own scientists. Understanding the need to tackle both pathways in COPD—and aware of competitor candidates in the hopper, including one that bound ST2—the company ultimately had to make some “courageous decisions,” Barr said. These included taking a prior COPD molecule offline and going back to the drawing board to reinvent its potential IL-33 label “to make sure that we had a molecule that could block signaling through both arms of the pathway, through both the reduced form and the oxidized form, knowing that we wouldn’t be first, but striving to be best.” “When we put [tozorakimab] into the clinic, we firmly believed that we had a differentiated molecule, and we saw the other molecules blocking just ST2 or partially blocking IL-33, unable to deliver two positive pivotal studies in COPD,” Barr explained. “We kept marching forward because we believed our molecule was differentiated, and now I think we have the clinical validation that supports that.” Ultimately, AstraZeneca finds itself on much better footing these days when it comes to potential biologic rivals to tozorakimab in COPD. Sanofi and Regeneron’s Dupixent, for instance, is approved to treat COPD exacerbations in patients with high eosinophil counts, but not low ones. Meanwhile, the future has become cloudier for other next-gen IL-33 candidates from Sanofi and Regeneron, as well as Roche, which have suffered trial flops in recent years. One other potential ingredient for AstraZeneca’s success in its duo of studies was that the company was “ambitious in the trial design, willing to look at an all-comers population,” Barr said, “and willing to enroll the most severe patients.” Prior studies for would-be biologics rivals in COPD “avoided enrolling” those patients, she pointed out. She also highlighted the Big Pharma’s painstaking design of exacerbations in its trial, which “gave us a very rigorous readout,” and pointed to “the extra effort and investment” the company put in to understand the effect of mucus plugs in patients. Barr described mucus production as a “key feature in disease diversity,” noting that mucus plugs—obstructing clumps of mucus that block patients’ airways—are associated with worse outcomes in COPD. In its data announcement, AstraZeneca noted that an integrated analysis of Oberon and Titania found tozorakimab “demonstrated a reduction in patients’ mucus plug score,” with the pharma claiming its biologic is the first to deliver such results in a broad COPD population. “So being able to reduce those mucus plugs, we expect, is an important part of driving benefit for patients who are living with COPD,” Barr said. Again touching on the breadth of the study populations, Barr added that tozorakimab “worked across all eosinophil levels in both current and former smokers across all levels of lung function,” which she suggested “really simplifies decision-making for clinicians, and it allows them to offer therapy to the broadest possible patient population.” In the highest patient eosinophil count group, tozorakimab helped chart a 43% reduction in exacerbation risk, which Barr stressed were “unprecedented data.” In the mid-level group, AZ’s drug delivered a 23% reduction and, in the lowest group, a 34% reduction in eosinophils, which Barr said suggests efficacy “in all patient subgroups.” As for AZ’s recent guidance upgrade on the medicine’s sales opportunity, the lift from a $3 billion to $5 billion range to $5 billion plus was informed by multiple factors, Barr said, including the fact that “in 2024, there were multiple competitors, and there aren’t anymore.” Additionally, “we know that this is a massive unmet medical need, and this is a really incredible set of data that we think will be very convincing to the clinical community,” Barr said. Looking ahead to a potential evolution of the COPD treatment landscape, Barr noted that most patients start treatment in the community with an option like a triple therapy, and for them, having an option like AstraZeneca’s inhaler Breztri will remain a “really important part” of that journey. But of the patients uncontrolled on triple therapy, which Barr described as “about half of them today,” just a “small fraction” are currently eligible for biologic therapy, which she emphasized AstraZeneca is working to change. Understanding that COPD is not a “one-size-fits-all” disease, AstraZeneca is also looking at its antibody drug Tezspire for patients with T2-driven disease, and the company continues to think about new mechanisms for tackling COPD through both systemic and inhaled drugs, Barr said.
988 Day: What to know about Oklahoma's mental health lifeline
On 988 Day, a crisis services expert explains what happens when you call, text or chat with the 988 Mental Health Lifeline and why you don't have to be in immediate crisis to reach out.
Legal complaint against FIFA to cover impact on women’s schedule
A legal complaint against FIFA has been extended to cover its “abusive conduct” towards the women’s game in Europe. The complaint by the European Leagues umbrella group, which includes the Premier League and Scottish Professional Football League (SPFL) as members, was first lodged with the European Commission in October 2024.
Why Life’s Origin Can Only Be Explained by Design
The reagents of the feedstock are never produced by processes as on the early Earth. Production requires substantial energy and controlled industrial procedures
Explainer: Why Air India's funding call has come under political scrutiny in Singapore
Air India's request for about $1.5 billion in funds from its owners — Tata Sons and Singapore Airlines — has sparked a debate in Singapore over state investor Temasek's exposure to the Indian carrier.
‘Texas is the center of political conversation,’ according to MS NOW host Jen Psaki
Ahead of the RNC's Dallas midterm convention, the former White House spokesperson explains why Texas leads 2026 midterm politics.
In-studio: SCRMC talks upcoming seminar, ‘Your Health Explained’
Two representatives from SCRMC join Trey to talk about an upcoming event!
Many states have legalized marijuana in some form, but under federal law it remains a controlled substance. That conflict creates challenges when cannabis-related businesses seek banking and other financial services from federally regulated institutions. In this video, GAO Director Courtney LaFountain explains: • The federal guidance available to financial institutions serving cannabis-related businesses • Why banks must conduct enhanced due diligence and file additional reports • What financial institutions consider when deciding whether to serve the cannabis industry • Why cannabis businesses may face higher banking fees and limited access to loans • How restrictions on payment processing
Many states have legalized marijuana in some form, but under federal law it remains a controlled substance. That conflict creates challenges when...
Politics, Pubs, Parades, + the Parish: Jim McGreevey, Part 3
McGreevey also shares his thoughts on political leadership, family, faith and forgiveness, explaining why real change begins.
How Jalen Hurts showed he embraced Eagles' new offense
Jalen Hurts has embraced the Eagles’ new offense. Parks Frazier explains how he knew.
Former ref explains Arsenal-Chelsea red-card decision
Dermot Gallagher has backed the referee’s decision not to send off Gabriel Magalhaes for a kick to Emi Martinez’s head, explaining that the defender got the ball.Photo by Ryan Pierse/Getty ImagesA...
Week 3 schedule for Lubbock-area high school football
Here's the complete schedule for Week 3 games involving Lubbock and the South Plains.
Video: Opinion | What ‘Hyperpolitics’ Explains About This Era
The political historian Anton Jäger on his theory of “hyperpolitics.”
Swedish results in maths, reading and science plummet to historic low in new Pisa poll
Swedish pupils have never before been as poor in mathematics, reading comprehension and science in any Pisa survey in 25 years, in shock results that present a stark wake-up call.
A men's health doctor says many men with low testosterone are getting misdiagnosed — and missing lab tests could be why
Sometimes men are treated for depression when low testosterone is the real cause. A men's health physician explains the signs, the tests, and what to do next.
Scientists Discover a Hidden Defect That Could Explain Why IBD Keeps Coming Back
A hidden molecular defect in inflammatory bowel disease may help explain why flare-ups can return even when patients appear well. Even when inflammatory bowel disease appears under control, intestinal cells may remain primed to die. In a WEHI-led study, researchers found this hidden molecular defect in patients with few or no symptoms, and higher levels
'The fan experience has certainly been ruined'
Lower down this page you can see Forest fan Ellie Molloson explain she's sometimes "scared" to celebrate a goal given VAR can intervene. Richard: Not that it makes any difference now, but 'clear and Obvious' never came into this decision from either VAR or the referee.
“Sex and the City” star Sean Palmer details heartbreak of being cut from first film: ‘Disappointing’
The actor explained that the movie would’ve featured a scene in which his character tied the knot with his partner, Stanford Blatch.
Howie Roseman explains why Eagles drafted Jihaad Campbell
Jihaad Campbell’s ability to cover, blitz and rush made him valuable to the Eagles
Aidan Chiles Details First Game Working With Chip Kelly
Aidan Chiles and Chip Kelly showed flashes of an exciting connection in Northwestern’s season opener, with the quarterback praising Kelly’s playcalling and explaining how the duo worked together in the Wildcats’ 34-18 win.
Why employee mental health is your best investment
Wedgwood expert Brina Tiemeyer explains how mental health support, strong managers and healthy workplace cultures strengthen the workforce.
Why employee mental health is your best investment
Wedgwood expert Brina Tiemeyer explains how mental health support, strong managers and healthy workplace cultures strengthen the workforce.
How Tennessee can protect the benefits workers earn
Health benefit costs are spiking for Tennessee workers. A former lawmaker explains why state mandates are to blame.
Why is Sunderland vs Arsenal at 8pm on Saturday?
BBC Sport's Ask Me Anything team explains why Saturday's Premier League fixture between Sunderland and Arsenal is kicking off at 8pm
“Really Angered Phillies Fans” – Philadelphia Sports Reporter Bemoans Ronald Acuna Jr.’s ‘Curtain Call’ After HR in Braves Comeback Win
NBC Philadelphia sports anchor and Phillies analyst John Clark explained why Braves right fielder Ronald Acuna Jr. became a villain in the eyes of Phillies fans after his heroics on Sunday night, which helped Atlanta complete a dramatic comeback at Citizens Bank Park.
Prof Elizabeth Streicher unravels the science behind drug-resistant TB
Prof Elizabeth Streicher of the Division of Molecular Biology and Human Genetics delivered her inaugural lecture on Tuesday 1 September 2026. Her research focuses on the transmission and spread of Tuberculosis (TB). Knowing where TB transmission is happening can help to stop it from spreading. Prof Elizabeth Streicher of the Division of Molecular Biology and Human Genetics in the Faculty of Medicine and Health Sciences delivered her inaugural lecture on Tuesday 1 September 2026. The title of her lecture was Decoding tuberculosis: the evolution of technology, epidemiology and the Mycobacterium tuberculosis genome. Streicher explained to Corporate Communication and Marketing how molecular epidemiology (using genetic information to track how and why diseases spread through populations) has improved our understanding of where drug-resistant TB comes from, how it spreads and how drug resistance evolves within and between populations. Tell us more about your research and why you became interested in this specific field. Overall, our research group studies the genome (complete set of DNA instructions found in a cell) of Mycobacterium tuberculosis, the bacteria that cause tuberculosis (TB) disease. Various regions of the genome are interrogated to study different aspects of the disease. My main focus has been on the epidemiology of tuberculosis – how the bacteria’s genome changes over time and what this tells us about the transmission and spread of the disease. How would you describe the relevance of your work? If we understand how the bacteria that cause TB change and spread, it can assist in combating TB globally. How has molecular epidemiology helped improve our understanding of drug-resistant TB? Molecular epidemiology was very important in drug-resistant TB as it was originally believed that bacteria that become resistant to antibiotics would be less fit and not be able to transmit. But it was shown that they can transmit, and therefore have to be monitored to identify hotspots of transmission and outbreaks, etc. Can you tell us briefly about the spoligotyping technique and its advantages for studying drug-resistant TB? Spoligotyping (a molecular technique used to identify and track specific strains of TB bacteria) does not detect drug resistance, but since the technique is relatively quick to do, it can be very useful in real-time situations, e.g. to monitor outbreaks of drug resistance. Why are interrupting transmission chains and identifying genomic hotspots important for controlling the spread of TB? Knowing where TB transmission is happening can assist in allocating resources to those areas to stop future transmission and spread of TB. Higher education can be challenging. What keeps you motivated when things get tough? Students – how they are so passionate and dedicated to learning and contributing to research and society as a whole. What aspects of your work do you enjoy the most? Again, the students and colleagues! But also the fact that it is continuously changing and thereby we are learning and expanding our knowledge. In the end, I know that we contribute to a better society in our small way. Tell us something exciting about yourself that people would not expect. Even though I love hiking (day and multi-day hikes) and being outside, I really do not like camping! How do you spend your free time? I love hiking (wellbeing in nature) and like to watch most sports. ©Higher Education Media Services. Subscribe
Trump looms over WA’s 3rd District race for U.S. House control
ILWACO, Pacific County — Rep. Marie Gluesenkamp Perez stood inside a brewery in this sleepy town where the Columbia River meets the Pacific Ocean, explaining to a crowd of supporters
Limei Xu: Unraveling water’s hidden physics
From its unique properties to the physics of phase transitions, Limei Xu explains how studying water can reveal fundamental laws of nature.
The Manhunter speaks: ‘Lanterns’ star talks big twist
‘Lanterns’ star behind the Manhunter explains how the reveal ‘reframed everything’ for the character.
The Manhunter speaks: “Lanterns” star explains how the big twist ‘reframed everything’
The actor behind the character talks the episode 4 reveal.
Scientists say love follows hidden mathematical rules
Could math help explain why some relationships survive life’s inevitable stresses while others slowly fall apart? Researchers have spent decades developing mathematical models that treat romantic feelings as changing systems, revealing patterns in attraction, emotional reactions, conflict, and recovery.
The science behind the perfect pole vault | News | Budapest 26
Mondo Duplantis can often make the pole vault look easy as he clears world-record heights. But as Athanassios Bissas explains, there is so much more complexity to it. The Greek professor unpicks the science behind the perfect pole vault.
Influencers, weed and disruptions stir controversy at U.S. Open
Social media influencers and other spectators are stirring controversy at this year’s U.S. Open, with viral videos, bright lights and other distractions prompting complaints from tennis fans and some of the sport’s biggest stars. The debate intensified during Naomi Osaka’s first-round match against Anastasia Zakharova, when people in a courtside suite were seen filming themselves […]
The core anti-Pangram constituency is phony writers
Welcome to The Closing Argument, our verdict on the news, plus everything The Argument published and appeared in this week. The Verdict, by Kelsey Piper A lot of people hate AI for drowning the internet in slop and displacing human creatives. You might think that these people would be thrilled by a program that can identify and flag AI-generated work. But many people who hate AI also hate Pangram, an impressively accurate AI detector that produces very few false positives, according to high-quality independent research. This loathing found its most recent expression in a bizarre Wired article that amplifies a wide range of false arguments from Pangram skeptics: that AI detectors are racist (they’re not) or ableist (they’re not)1 or don’t work (this one does)2. Rather than starting from the premise that it would be really valuable to have a working AI detector and scrutinizing Pangram to make sure it lives up to that promise, the article starts from the premise that Pangram obviously has bad vibes and sets out to discover why. (One answer: The CEO microwaved lunch during an interview!) Why aren’t writers who resent Pangram more eager to distinguish themselves from posters who are having ChatGPT ghostwrite all their work? There are a few different things at play, but I think one key dynamic is this: These are often the same people. A core constituency for arguments like Wired’s is “writers” who are using AI to write their posts but resent this fact being made public. They stand to lose from AI detectors because AI detectors call them out. Share When Substack announced a partnership with Pangram, a sizable fraction of the platform’s authors rose up in outrage. Some people had experience with other AI detectors that didn’t work, and some felt that AI writing ought to be encouraged — both of which are fair enough. But the fury was fueled by authors passionately insisting that Pangram kept wrongly accusing them on almost every post they published. Pangram can be wrong, especially on short passages. But in the overwhelming majority of cases where Pangram looked at a whole blog post rather than a single paragraph, the program correctly detected work as AI. Even if we can’t be 100% sure in any individual case, we can notice the trend in the aggregate. Wired quotes Sam Illingworth, a professor of critical AI literacy at Edinburgh Napier University, who said, “I don’t think [AI detectors] work. … I think that detectors are prejudiced against certain people.” This spring, he said that he used AI for research and editing; this summer he acknowledged that in addition to research and editing, he also uses it “now and then for a turn of phrase I keep.” Pangram informs us that most of his posts are 100% AI-written (some are mixed AI-and-human) and that 100% AI-written posts started appearing last year. The favorable interpretation is that, as someone whose recent work Pangram consistently mistakes for AI, Illingworth sees Pangram’s flaws firsthand. The unfavorable interpretation is that the tool’s credibility trades off against his own, because its account of who writes his posts is not consistent with his. Illingworth is not alone in insisting the detector does not work. “It’s a Monday night in late July, and I’m pasting my own Substack draft into an AI detector for the first time. Not because I’m worried. Because I’m curious. I wrote every word of it myself, the way I write everything, out loud in my head first, in a rhythm that still carries the accent of a language I learned to think in before I learned to write in this one,” begins one Substack post by an author indignant that Pangram flags her writing as AI. “That’s the part I had to sit with before I could write this.” If you, like me, have worked with AIs a lot, you won’t even need Pangram there. The author of that piece is AI. It is obviously AI! I checked 10 other posts on the blog, and they were also obviously AI! “I have spent 22 years as an award-winning author and essayist. And now this bullshit tool that learned from MY writing is going to accuse me of plagiarism,” popular Substack writer Carlyn Beccia wrote in an anti-Pangram post. “For the last and final time, AI DETECTORS DO NOT WORK.” Here’s what her writing sounded like in 2020: “Most success stories revolve around one person who believed enough in you to say — give it a try. We call these people muses, but they are so much more than that. They are the strong man giants whose shoulders we stand on so we can see the horizon. Throughout the editing process, I am sure my editor felt less like a giant of greatness and more like Atlas with the world on her shoulders.” Pangram says it was 100% human-written. (So were other articles of hers in 2020.) And here’s what it sounds like now: “And then there is the reshuffling, which sounds like paperwork until you remember that empires have always loved paperwork. The Trump regime recently moved special education oversight from the Education Department to HHS. That is not a minor bureaucratic transfer. It changes the frame.”3 Pangram says this is mostly AI. I am not convinced that Pangram is wrong. In my own experience, Pangram is very effective on long texts — if it marks a long essay as AI, the essay was either written by AI or deliberately written to sound like AI. On tweet-length or paragraph-length texts, it’s not perfectly reliable. It seems to work just as well for non-native English speakers as for native speakers. While I have seen dozens of claims of pre-2022 text returning a positive result on Pangram, I have tried repeatedly to corroborate those and have never once succeeded. To be clear, I’m absolutely not saying that complaining about Pangram suggests a writer is a cheat. There are plenty of other concerns. Most are mistakenly premised, such as the false claim that Pangram trains on work you put into it, but others are reasonable: It’s unreliable on sufficiently short text segments; it creates an internet witch-hunt mentality when there are defensible uses of AI; people who are open about their AI use are sometimes blamed, when the only people really doing something wrong are the ones who hide it; and it isn’t perfect, so a single positive result shouldn’t be taken as decisive proof of misconduct. I’m happy to concede that Pangram is imperfect and possible to over-rely on. If an author’s posts are mostly non-AI and one scans as partially AI, this could be a mistake. It’s also possible to defeat Pangram with intentional effort. If you think we need something more robust and more reliable, fine! But if you don’t like AI and don’t like Pangram, your attitude really ought to be that it’s a shame that our existing tools for AI detection are imperfect, and it’s important to invent better ones. If your stance is instead that AI is evil and so is looking for AI, then ultimately you’re contributing to the sloppification of the internet. You’re making it harder for people who write their own text to distinguish themselves, and providing cover for authors who are definitely not writing their own text. Subscribe Top stories this week, by Kobe Yank-Jacobs Commentators often worry that the decline of reading could mean the decline of liberal democracy — but deliberative governance actually predated widespread literacy. This week, Maibritt Henkel pointed out that many liberal cultures thrive on a culture of raucous, interactive debate, which can happen in-person as easily, if not more so, than in text. Read on, dear reader, to learn more. It may actually cheer you up: [ ](https://www.theargumentmag.com/p/reading-wont-save-liberalism) [ Reading won’t save liberalism ](https://www.theargumentmag.com/p/reading-wont-save-liberalism) Maibritt Henkel · Sep 1 [ Read full story ](https://www.theargumentmag.com/p/reading-wont-save-liberalism) It used to be bad to downplay climate change (if we mean denying its reality). Today, it’s actually good to downplay climate change (if we mean keeping the issue out of political fights so we can make real progress). This counterintuitive view is called “climate hushing,” and contributor Alex Trembath argued that it’s the key to enacting good policy going forward. Get up to speed on the latest in climate politics: [ ](https://www.theargumentmag.com/p/we-wont-stop-climate-change-by-talking) [ We won’t stop climate change by talking about it ](https://www.theargumentmag.com/p/we-wont-stop-climate-change-by-talking) Alex Trembath · Sep 2 [ Read full story ](https://www.theargumentmag.com/p/we-wont-stop-climate-change-by-talking) Canada’s Prime Minister Mark Carney is standing up for the forces of liberalism against Donald Trump’s assault on our closest ally. So, why is one prominent left-wing commenter attacking Carney? Columnist Matthew Yglesias explains: [ ](https://www.theargumentmag.com/p/when-economic-liberty-means-central) [ When "economic liberty" means central planning ](https://www.theargumentmag.com/p/when-economic-liberty-means-central) Matthew Yglesias · Aug 31 [ Read full story ](https://www.theargumentmag.com/p/when-economic-liberty-means-central) 🌟Abundance Wins of the Week🌟 Shout out to my home state of California, whose legislature passed two housing bills this week. One requires a housing density minimum in transit-oriented areas of the state’s most transit-rich cities (Los Angeles, Sacramento, San Francisco, Oakland, San Jose, San Diego, and Long Beach). Another bill closes two common loopholes used by third parties to delay housing projects, including an opportunity to challenge maps of a given lot created by the developer after a project has been approved. Shout out to our big-state rival, Texas, where pro-housing SB 785 took effect this week. The new state law requires municipalities to have at least one district permitted for manufactured housing without a special permit. This will promote zoning changes in 44% of municipalities. The company Fervo Energy signed a deal with Google for what is set to be the world’s largest enhanced geothermal facility, proving a technology can work at a scale that could be crucial to a decarbonized, energy-abundant economy. Share Worth watching… This week, forecasting legend Nate Silver joined Jerusalem, Matt, and Jeremiah on a crowded episode of the pod. It was a party. And speaking of parties, our round table debated the factional lines within the Democratic Party: Is it possible to be center-left and also anti-establishment? Watch or listen to find out: The Rio Grande Valley in Texas is one of the areas that swung hardest toward Trump in 2024, but musician Bobby Pulido is running to flip it back. Right now, The Argument/Split Ticket’s model has him running 1.1 points behind his Republican opponent in a district Trump won by 18 points. Tune in to find out how he differs from national Democrats and what he thinks he can to do win this seat. On Thursday, Bernie Sanders was among the first politicians to call for a ban on superintelligence. My guest this week, Andrea Miotti, has been lobbying to ban superintelligence for several years, most recently in the U.K., U.S., and Canada. I asked him how he gets legislators to take speculative risks seriously, and we dug into what plans might look like to actually pass a ban. Listen to learn more: What’s News with The Argument The Argument recommends, by Kobe Yank-Jacobs If we ever lose track of Justin Zuckerman, I’ll have the team split up and check all the movie theaters in the city. I’m shocked (and a little jealous) at how often he gets out to see good cinema. This week, he brings us It Ends, a “horror-ish movie,” which he described as a “Gen Z Waiting for Godot.” I was intrigued before he added that it was “funny, dark and existential” — at which point I was fully locked in. I guess I also had existential themes on the mind this week. One morning, a single line from a poem I read long ago just came to me: “Is death a stretch of time in which a life is just a flash?” The poem is called “From 20,000 Feet” by Heather McHugh. I suggest the version in The Vintage Book of Contemporary American Poetry, which, by tradition, my best friend and I always bring backpacking, extra weight be damned. We’ll stay thematically dark for just one more rec from senior editor John Robert Thomason, whose upcoming trip to Baltimore reminded him to suggest Michael Clune’s memoir White Out (about being addicted to heroin in Baltimore in the 1990s). Ben Lerner’s blurb called it _“_Disturbing, brilliant, hilarious—it’s as if Proust had written Jesus’ Son.” John told me this “seems accurate, with the caveat that I’ve never read Proust.” I, personally, have also shelved Proust until retirement. At this point, I was a little concerned for the team since all of us tossed out such psychologically grim material — maybe we’re all down about the end of summer — but thankfully, at least a few of us were into more upbeat selections. Milan Singh recommended Made In’s 5-quart stainless clad saucier, suggesting he had some fun in the kitchen. Jeremiah Johnson asked if he could recommend yet more Carly Rae Jepsen. Once denied, he offered up Game Changer instead_,_ calling it “the most wildly creative game show, maybe in the entire history of the genre.” Eli Richman mentioned _Lucky, “_a B-tier show with an A-tier cast and an S-tier theme song.” I suppose he was recommending the song, Horns of a Bull. Still, despite these cheerier recs, I couldn’t help but be concerned that we were subconsciously worried about racing toward summer’s end — the end of swim trunks and splashing around. Then a message landed reminding me of the three-day weekend to come. A whole extra day for sunshine. One more swim in the lake. I was grateful this called to mind yet another line from a poem, one by Mary Oliver, the patron saint of every gorgeous summer day (and about whom a documentary is now out). Speaking to God in the poem “Thirst,” she wrote: grant me, in your mercy,a little more time. Love for the earthand love for you are having such a longconversation in my heart. We have merch! We have quarter-zips, keychains, hats, and stickers. Each one is a great conversation starter in its own way. Buy them here. Subscribe More to read: [ The Opening Argument ](https://www.theargumentmag.com/p/seeing-like-an-elite)[ Seeing like an elite ](https://www.theargumentmag.com/p/seeing-like-an-elite) Kobe Yank-Jacobs · Sep 4 What do Americans hear when they watch Sen. Bernie Sanders or Vice President JD Vance rail against the elite? Are they thinking of right-wing tech billionaires? Imperious college professors? Liberal magazine writers? [ Read full story ](https://www.theargumentmag.com/p/seeing-like-an-elite) [ The Weekly Scroll ](https://www.theargumentmag.com/p/god-is-back-on-the-timeline)[ God is back on the timeline ](https://www.theargumentmag.com/p/god-is-back-on-the-timeline) Jeremiah Johnson · Sep 5 This week, we’re talking about Substack’s new religious debates, the continuing MAGA influencer scandal, how to retire from YouTube, and aura battles. [ Read full story ](https://www.theargumentmag.com/p/god-is-back-on-the-timeline) 1 This was a legitimate thing to worry about, but doesn’t seem to be a problem given the actual technology: Marijke Van Vlasselaer, Filip Van Droogenbroeck, and Bram Spruyt’s 2026 paper looks at whether Pangram is less accurate when evaluating the work of non-native speakers of English. It isn’t. That’s because Pangram isn’t really looking at how “unusual” a piece of writing is but whether it has the characteristic patterns of LLMs. The Wired article makes an odd gesture at a different Pangram-is-racist argument. There were several controversies this summer during which upcoming books were canceled after being discovered to be AI-written: “The three novels mentioned earlier — Shy Girl, Daggermouth, and Call Me, easily publishing’s biggest AI-detection scandals — were all written by writers of color.” But come on! As Zvi Mowshowitz put it: “They were not primarily written by people of color. They were primarily written by AIs.” That’s the whole problem! And as my colleague Jeremiah Johnson recently observed with respect to Cambridge’s Arday scandal, a community being unwilling to call out fraud if it’s perpetuated by people of color is not an anti-racist tendency; it is ultimately quite racist. 2 Many non-Pangram detectors don’t work, but many possible airplane designs also don’t work, and no one considers this a general argument against aviation; the thing that matters is whether any detection works. 3 The phrase “empires have always loved” mysteriously became all the rage in the last few years. See here, here, here, here and here. Before 2025, the only use of that phrase I have been able to find is a single Tweet. The logic of the sentence, too, is incoherent in an AI-characteristic way. “...sounds like paperwork, until you remember that empires have always loved paperwork”? Does remembering that make it sound less like paperwork? It’s a craft-ful sentence, but what is it actually saying??
A trucker explains what record diesel prices mean for his business
Monte Wiederhold runs a trucking company in northwest Ohio. He explains how problems overseas affect businesses at home.
Richard Sherman blasts Bengals defense in AFC North prediction
Richard Sherman explained why a healthy Joe Burrow still isn't enough for him to pick the Cincinnati Bengals to win the AFC North in 2026.
Final Fantasy 7 Revelation Devs Don't Want The Ending 'Explained To You By Someone Else'
No spoilers, please
Richard Barrera explains why he should be the next State Superintendent
Richard Barrera, a candidate for California state superintendent, shared his views on recent changes to the California Department of Education, his campaign priorities, and his vision for public schools in an interview on California Politics 360 this week.
Exodus Ending and Character Fates Change Based on Your Choices
Exodus is an upcoming sci-fi RPG that will account for the decisions you make in its story, and its narrative director explains how it'll all be reflected in the end.
Big Ten issues statement explaining why Michigan was given one more chance at Hail Mary
Michigan snatched victory from the jaws of defeat on an extremely controversial play.
Georgian National Charged in US with Laundering $1.3B in Health Care Fraud Scheme
A federal grand jury in Boston has indicted a Georgian national on charges of conspiracy to launder proceeds from a $1.3 billion health care fraud scheme.
Scientists find breast cancer cells hiding behind protective “shields”
Researchers have mapped breast tumors in striking detail and uncovered hidden pockets of dormant cancer cells that may help explain why cancer can return after treatment. Unlike rapidly dividing cells, these quiet cells can essentially hibernate, allowing them to evade chemotherapy and reactivate later. The team found that they are often surrounded by immune cells and connective tissue cells that may act like a protective shield.
Why You Shouldn’t Rinse Your Mouth After Brushing Your Teeth, According to a Dentist
After brushing, do you rinse your toothpaste out of your mouth? A dentist explains whether rinsing or not rinsing is better, and why.
Big Ten Explains Michigan’s Controversial Hail Mary Setup
The Big Ten explained why Michigan received one final second before Bryce Underwood’s game-winning Hail Mary against Western Michigan.
An evangelical explains what people get wrong about her faith
A new book from writer Bonnie Kristian argues that evangelicalism has been “monstered.” What aren’t we getting right?
Kokua Line: Why can’t new business register with state?
Question: Can you check what is going on with the slow approval times at the State of Hawaii DCCA Business Registration Office? Historically, if you paid the expedited review fee, your registration documents for a new entity would be approved within a week or sooner. Now, even paying the expedited review fee, I have been patiently waiting for months. My filing to form a new business submitted in June still has not been approved. Without the state’s approval, I cannot open a bank account, sign a lease, hire employees, or start my business. This has resulted in damages due to the delays. My emails to the DCCA have not been responded to. I heard that there is an issue with a new vendor of their supposed updated system, but forming a new business or other business registration tasks seem to have come to a standstill. I heard that they are working on May submissions now. I cannot believe that this unacceptable delay has not been publicized, complaints from the public more prevalent, and the elected officials not having been told by their constituents to immediately address this problem.
Connecticut doctors explain how social connection boosts health
“In terms of brain health socialization is like taking your brain to the gym,” said Dr. Kristina Zdanys, a psychiatrist at UConn Health.
Major Political Parties in Türkiye Explained
According to official figures, Türkiye has 190 political parties. This number may sound incredibly high and can be reduced to below 100 if you don’t...
Big Ten explains controversial ending to Michigan-Western Michigan
The Big Ten defended the controversial clock ruling that allowed Michigan to secure a narrow win over Western Michigan.
JJ Buchanan explains Michigan's game-winning Hail Mary catch
Michigan wide receiver Buchanan reflects on his game winning Hail Mary catch that saved the Wolverines on Saturday.
Can science explain what happens to us after we die?
A quantum physicist discusses the idea that quantum theory relates to consciousness and how it could exist independently of the brain.
Highlights/scores: High school sports (9/5/26)
CENTRAL ILLINOIS (WCIA) — Check out the latest scores from high school sports around the state, plus highlights from Leroy’s Saturday night football action. FOOTBALL Leroy 34, Tremont 6 BOYS SOCCER Southeast 1, Beardstown 1 Washington 2, Centennial 0 Charleston 3, Newton 0 Glenwood 2, Althoff 0 Jacksonville 2, Jerseyville 0 Pleasant Plains 5, Riverton […]
Cavaliers' Donovan Mitchell Reveals Why 2026-27 Will Be Different
Cleveland Cavaliers star Donovan Mitchell explained why he thinks next season could be different for the team, especially on offense.
Matt Quatraro Explains Royals Starter's Rough Outing Before Rematch
Seth Lugo gets a second crack at Max Scherzer tonight, six days after giving up nine earned runs in Cleveland.